Venture Capital

With a fresh $12M in funding, Canadian fintech Common Wealth is using AI and a modern platform to bring retirement plans to underserved small businesses.

A new partnership introduces PBSerum®, a biologically inspired enzyme treatment, aiming to redefine skin quality in the multi-billion dollar aesthetics market.

L2L's new Execution AI, built on AWS, promises to move factories from reactive chaos to proactive intelligence, addressing a decade of stagnant output.

A top UK defense data expert moves to the private sector, highlighting the critical role of AI in the growing shadow war of economic espionage.

A new robotic platform with fingertip controls and remote surgery capabilities aims to overcome barriers to life-saving mechanical thrombectomy for stroke.

Ditching the old OEM model for a 'win-win ecosystem,' Chery bets on shared tech and green manufacturing. A global summit will test this bold new vision.

Orca Security partners with distributor TD SYNNEX, shifting its market strategy to rapidly expand access to its AI-powered, agentless cloud security platform.

Replimune halts a promising cancer therapy and cuts jobs after a stunning FDA rejection, citing a 'failed' system and inconsistent regulatory process.

Allogene Therapeutics faces a make-or-break moment as it prepares to unveil crucial trial data for its 'off-the-shelf' cancer therapy, cema-cel.

With a $2.135M financing round complete, Golden Shield Resources turns its focus to permitting its promising Marudi Mountain gold project in Guyana.

A high-level visit to General Atomics signals a major U.S. push for fusion energy, blending private innovation with public funding to win a global race.

A new collaboration between Emporia Research and Definitive Healthcare promises unprecedented accuracy in recruiting healthcare decision-makers for vital research.

The Chinese EV maker released landmark ESG and climate reports, boosting transparency as it navigates tough regulations and mixed investor sentiment.

At a landmark CMS event, Centauri, HealthEx, and Doctronic demo AI-powered apps promising a future where patient data is secure, accessible, and intelligent.

With a massive $54M Series A, Vivatides Therapeutics aims to solve RNA's biggest delivery problem, unlocking new treatments for a host of chronic diseases.

Jetstream Venture Fund's deals with Surf Therapeutics and Hill Research signal a new era of accessible venture capital backing transformative technologies.

A new facility in Estonia is breaking Europe's reliance on China for critical minerals essential for electric vehicles and wind turbines.

At analytica 2026, Haier Biomedical unveiled its 'In Europe, For Europe' strategy, challenging market leaders with integrated solutions and local roots.

A new partnership combines local infrastructure with global expertise, aiming to streamline development for startups and solidify Singapore's biotech leadership.

As local newsrooms struggle, a new program offers $20,000 grants and expert training to build sustainable journalism businesses across California.